A case of severe tongue ulceration and laryngeal inflammation induced by low-dose nicorandil therapy [10]

British Journal of Dermatology

Volumn 151, Issue 4, 2004, Pages 939-941

  Jang, H S ^a   Jo, J H ^a   Kim, B S ^a   Jun, G J ^a   Lee, J B ^a   Kim, M B ^a   Oh, C K ^a   Kwon, K S ^a  

^a Pusan National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

NICORANDIL;

ADULT; CASE REPORT; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DRUG TOLERABILITY; GASTROINTESTINAL SYMPTOM; GRANULATION TISSUE; HEADACHE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LARYNGEAL INFLAMMATION; LARYNX DISORDER; LETTER; LOW DRUG DOSE; MALE; MYALGIA; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; RASH; RELAPSE; SIDE EFFECT; SYNCOPE; TONGUE DISEASE; TONGUE ULCER; ULCER;

HUMANS; LARYNGITIS; MALE; MIDDLE AGED; NICORANDIL; STOMATITIS, APHTHOUS; TONGUE DISEASES; VASODILATOR AGENTS;

EID: 8344257960     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.06199.x     Document Type: Letter

References (11)

1. Desruelles F, Bahadoran P, Lacour JP et al. Giant oral aphthous ulcerations induced by nicorandil. Br J Dermatol 1998; 138: 712-13.
2. Reisberger EM, Abels C, Landthaler M, Szeimies RM. Histopathological diagnosis of onychomycosis by periodic acid-Schiff-stained nail clippings. Br J Dermatol 2003; 148: 749-54.
3. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med 1998; 9: 306-21.
4. Porter SR, Scully C. Adverse drug reactions in the mouth. Clin Dermatol 2000; 18: 525-32.
5. Patel HM, Santani DD, Goswami SG. Evaluation of the effects of nicorandil on experimentally induced gastric ulcerations. Pharmacology 2001; 63: 154-9.
6. Agbo-Godeau S, Joly P, Lauret P et al. Association of major aphthous ulcers and nicorandil. Lancet 1998; 352: 1598-9.
7. Frampton J, Buckley MM, Fitton A. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs 1992; 44: 625-55.
8. Krumenacker M, Roland E. Clinical profile of nicorandil: an overview of its hemodynamic properties and therapeutic efficacy. J Cardiovasc Pharmacol 1992; 20 (Suppl. 3): S93-102.
9. Camm AJ, Maltz MB. A controlled single-dose study of the efficacy, dose-response and duration of action of nicorandil in angina pectoris. Am J Cardiol 1989; 63: 61-5J.
10. Shotts RH, Scully C, Avery CM, Porter SR. Nicorandil-induced severe oral ulceration: a newly recognized drug reaction. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 87: 706-7.
11. Scully C, Azul AM, Crighton A et al. Nicorandil can induce severe oral ulceration. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2001; 91: 189-93.